1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The link for this program now points to a previous cycle.
Historical funding: Varies
Prior eligibility: Researchers and institutions with expertise in digital healthcare solutions.
Using Innovative Digital Healthcare Solutions to Improve Quality at Point of Care (R21/R33) is a grant from the National Institutes of Health, administered by the Agency for Healthcare Research and Quality (AHRQ), that funds research developing and testing digital tools and technologies that improve the quality, safety, and efficiency of healthcare at the point of care. The program supports both exploratory and development-stage research projects using digital health solutions such as clinical decision support, patient monitoring, and telehealth applications. Eligible applicants are researchers and institutions with expertise in digital healthcare solutions. The deadline is August 1, 2026.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article